| Type | Description |
|---|---|
| Definition | suppression of tumorigenicity 2 |
| Date | Results | Publications |
|---|---|---|
| 2021-04-17 13:39:00 | Interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) axis in idiopathic inflammatory myopathies and its association with laboratory and clinical parameters: a pilot study. | 32222805 |
| 2021-04-03 13:35:00 | IL-33 and its decoy sST2 in patients with Alzheimer's disease and mild cognitive impairment. | 32505187 |
| 2021-04-03 13:29:00 | Superior prognostic value of soluble suppression of tumorigenicity 2 for the short-term mortality of maintenance hemodialysis patients compared with NT-proBNP: a prospective cohort study. | 32460670 |
| 2021-03-20 13:35:00 | Soluble ST2 proteins in male cachectic patients with chronic heart failure. | 33549461 |
| 2021-02-27 13:47:00 | Blocking of the IL-33/ST2 Signaling Axis by a Single-Chain Antibody Variable Fragment (scFv) Specific to IL-33 with a Defined Epitope. | 32971846 |
| Type | IDs |
|---|